Date of management change: January 15, 2019
Cresskill, NJ-based Vascular-Therapies Appointed John McDermott as Chief Executive Officer
Vascular Therapies, Inc., a privately-held late-stage biopharmaceutical company, is developing the Sirolimus-eluting collagen implant for local, perivascular drug delivery.
John McDermott is Chief Executive Officer at Vascular Therapies. Previously, John held various senior HR leadership roles in the industry.
News
Short ProfileName: John McDermott
Title: Chief Executive Officer
Company: Vascular Therapies
Industry: Pharmaceuticals
Current Contact InfoEmail: **************@vasculartx.com
Phone:.***.***.*31*
To get full contact details, please sign in or
Other IT executives who recently changed jobs as well: Marous Dan, Murray Eliot, Forman-Cangṳu Jennifer, Webb Pam, Nissel James, Kelly Lou, Laymon Joe, Kumaran Sanal, Hansen Matt, Acenas Monica, Ohl Helanie
You can find the full directory of IT executives here.
How would you like to connect with 15,000+ IT executives in charge of $ millions in IT budgets? Find details here.
